Valuation: Danaher Corporation

Market Cap 141B 123B 114B 105B 199B 13,436B 203B 1,358B 533B 6,619B 529B 517B 22,756B P/E 2026 *
32.2x
P/E 2027 * 26.6x
Enterprise Value 141B 123B 114B 105B 199B 13,436B 203B 1,358B 533B 6,619B 529B 517B 22,756B EV / Sales 2026 *
5.41x
EV / Sales 2027 * 4.97x
Free-Float
71.14%
Yield 2026 *
0.72%
Yield 2027 * 0.77%
1 day+1.57%
1 week+0.57%
Current month+4.50%
1 month+8.40%
3 months+4.98%
6 months-16.50%
Current year-13.05%
1 week 189.78
Extreme 189.78
199.84
1 month 174.22
Extreme 174.2162
199.84
Current year 160.93
Extreme 160.93
242.8
1 year 160.93
Extreme 160.93
242.8
3 years 160.93
Extreme 160.93
281.7
5 years 160.93
Extreme 160.93
333.96
10 years 75.71
Extreme 75.71
333.96
Manager TitleAgeSince
Chief Executive Officer 62 31/08/2020
Director of Finance/CFO - 27/02/2026
Chief Tech/Sci/R&D Officer - 30/11/2021
Director TitleAgeSince
Director/Board Member 74 30/06/1999
Chairman 74 31/12/1983
Director/Board Member 69 31/12/1983
Date Insider Type Main position Quantity % Market Cap.
05-14Free

Director

2,379 0.0003%
05-14Free

Director

2,379 0.0003%
05-14Free

Director

2,379 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+1.57%+0.57%-3.14%-15.11% 141B
+0.45%+0.69%+22.36%+1.97% 196B
-1.16%-4.51%-22.67%+19.55% 144B
-0.49%-0.82%-56.89%-15.05% 66.54B
+0.96%-2.29%+17.02%+0.62% 53.09B
+0.61%-1.09%-27.71%-30.42% 44.12B
+0.52%+2.75%+8.15%+13.46% 37.93B
-0.19%-0.75%+6.55%+42.23% 36.96B
-2.20%-2.75%-21.00%-5.88% 29.41B
0.00%-1.32%-15.42%-19.79% 29.43B
Average +0.41%-1.03%-9.28%-0.84% 77.83B
Weighted average by Cap. +0.71%-1.03%-5.08%+0.10%

Financials

2026 *2027 *
Net sales 26.06B 22.79B 21.02B 19.42B 36.84B 2,485B 37.46B 251B 98.64B 1,224B 97.83B 95.7B 4,209B 28.37B 24.82B 22.89B 21.14B 40.12B 2,706B 40.79B 274B 107B 1,333B 107B 104B 4,583B
Net income 4.42B 3.86B 3.56B 3.29B 6.24B 421B 6.35B 42.58B 16.72B 208B 16.58B 16.22B 713B 5.35B 4.68B 4.31B 3.99B 7.56B 510B 7.69B 51.55B 20.25B 251B 20.08B 19.64B 864B
Net Debt - -
Logo Danaher Corporation
Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (40.5% of net sales); - life sciences equipment (29.8%); - biotechnology equipment (29.7%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (40.6%), China (10.7%) and other (48.7%).
Employees
59,000
Date Price Change Volume
10/07/26 US$199.05 +1.57% 3,847,652
09/07/26 US$195.98 +2.73% 2,657,124
08/07/26 US$190.77 -1.76% 2,502,661
07/07/26 US$194.19 +0.29% 3,248,899
06/07/26 US$193.62 -2.18% 4,663,821
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
199.05USD
Average target price
242.26USD
Spread / Average Target
+21.71%

Quarterly revenue - Rate of surprise